Preparation and drug-release property of amphotericin B-loaded chitosan-polylactic acid nanoparticles
Yan Wu,Tie-wei Wang,Ming-jun Li,Hong-xia Gao
DOI: https://doi.org/10.3969/j.issn.1673-8225.2009.34.018
2009-01-01
Abstract:BACKGROUND: Amphotericin B is firstly used to treat deeply fungous infection; however, the therapeutic effect is poor due to inability to cross the blood-brain barrier (BBB). Chitosan-poly (lactide) (chitosan-co-PLA) copolymer were synthesized by phase separation dialysis technique to overcome the shortage of amphotericin B. OBJECTIVE: To study the representation and drug-release ability of amphotericin B-loaded chitosan-co-PLA nanoparticles. DESIGN, TIME AND SETTING: A repeated measurement design was performed at the Nano-medicine and Nano-biotech Laboratory of National Center for Nanoscience and Technology from November 2008 to April 2009. MATERIALS: Chitosan with the average molecular weight of 3.4×105 and 93% deacetylation degree was produced by KaBo Biochemical Co., Shanghai. Amphotericin B was purchased from Sigma, USA. METHODS: Chitosan-polylactide copolymers were synthesized by ring-opening polymerization of DL-lactide (DLLA) and water soluble chitosan in dimethyl sulfoxide solution in the presence of triethylamine. The chitosan-polylactide copolymers, consisting of hydrophilic chitosan and hydrophobic polylactide segments, could form nanoparticles in water. Amphotericin B was incorporated into chitosan-polylactide polymeric nanoparticles by the phase separation-dialysis method. MAIN OUTCOME MEASURES: Particles size and polydispersity index were detected by laser particle size analyzer. The morphology of amphotericin B-loaded chitosan-polylactide nanoparticles was observed by environmental scanning electron microscopy. In addition, encapsulation capability, loading content and in vitro drug release of the amphotericin B nanoparticles was analyzed by UV-spectrophotometer. RESULTS: The mean diameters of chitosan-polylactide nanoparticles and amphotericin B-loaded nanoparticles were 114 nm and 153 nm (D, L-lactide/chitosan molar ratio 11:1), respectively. The nanoparticles possessed a uniform particles size distribution and spherical in shape. The entrapment efficiency and drug loading depended mainly on the copolymer composition ratio of D, L-lactide to chitosan oligomer. The encapsulation efficiency increased from (62.3±3.5)% to (90.7±2.8)%, drug loading increased from (7.8±1.2) % to (12.3±1.4) % with increasing the molar ratio of D, L-lactide to chitosan oligomer from 11 to 20. As polylactide weight ratio increased, the nanoaprticles size, encapsulation efficiency and drug-loading content increased, and the drug release rate decreased. CONCLUSION: Both ring-opening polymerization and phase separation-dialysis method are reliable and simple. The particle diameter is large, the encapsulation efficiency is great, and the in vitro drug release is sustained.